LORETTA MCNEAL: Open Payments
NPI 1992329825 · DRUMS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 70 payments from 16 companies in 2025. Trend: 2023 $21 · 2024 $883 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $167 |
| ABBVIE INC. | 7 | $151 |
| Braeburn Inc. | 7 | $137 |
| Otsuka America Pharmaceutical, Inc. | 6 | $131 |
| Neurocrine BioSciences, Inc. | 5 | $116 |
| Alkermes, Inc. | 4 | $104 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| Verona Pharma, Inc. | 2 | $53 |
| Lilly USA, LLC | 3 | $49 |
Products named: CAPLYTA, BRIXADI, INGREZZA, REXULTI, COBENFY, LYBALVI, BREZTRI, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
